Gansu Pharmaceutical Investment Group

Gansu Pharmaceutical Investment Group Co., Ltd. is a state-owned pharmaceutical enterprise group established in 2018 by the Gansu Provincial Government in China. As the leading 'chain master' enterprise for the province's traditional Chinese medicine (TCM) and healthcare industry, the company integrates TCM cultivation, processing, distribution, research and development, and pharmaceutical manufacturing. Its core commercial products include Xuanfei Zhishou Mixture (宣肺止嗽合剂) for cough relief and Yuanhu Zhitong Dripping Pills (元胡止痛滴丸) for pain management. The group operates several subsidiaries, including the publicly traded Gansu Longshen Rongfa Pharmaceutical, and actively drives the modernization and digital transformation of the regional pharmaceutical sector.